A European competence framework for industrial pharmacy practice in biotechnology

Jeffrey Atkinson; Pat Crowley; Kristien de Paepe; Brian Gennery; Andries Koster; Luigi Martini; Vivien Moffat; Jane Nicholson; Gunther Pauwels; Giuseppe Ronsisvalle; Vitor Sousa; Chris van Schravendijk; Keith Wilson

doi:10.3390/pharmacy3030101

A European competence framework for industrial pharmacy practice in biotechnology

Jeffrey Atkinson
, Pat Crowley
, Kristien de Paepe
, Brian Gennery
, Andries Koster
, Luigi Martini
, Vivien Moffat
, Jane Nicholson
, Gunther Pauwels
, Giuseppe Ronsisvalle
, Vitor Sousa
, Chris van Schravendijk
, Keith Wilson

Pharmacolor Consultants Nancy
Callum Consultancy
Vrije Universiteit Brüssel
Universiteit Utrecht
European Federation of Pharmaceutical Industries and Associations
Genzyme Flanders
Università degli Studi di Catania
Areta International
King's College London
European Industrial Pharmacists' Group

Research output: Contribution to journal › Article › peer-review

300 Downloads (Pure)

Abstract

Project Report: The PHAR-IN ("Competences for industrial pharmacy practice in biotechnology") looked at whether there is a difference in how industrial employees and academics rank competences for practice in the biotechnological industry. A small expert panel consisting of the authors of this paper produced a biotechnology competence framework by drawing up an initial list of competences then ranking them in importance using a three-stage Delphi process. The framework was next evaluated and validated by a large expert panel of academics (n = 37) and industrial employees (n = 154). Results show that priorities for industrial employees and academics were similar. The competences for biotechnology practice that received the highest scores were mainly in: . "Research and Development", . "Upstream" and "Downstream" Processing', " . "Product development and formulation", " . "Aseptic processing", ."Analytical methodology", . "Product stability", and . "Regulation". The main area of disagreement was in the category "Ethics and drug safety" where academics ranked competences higher than did industrial employees.

Original language	English
Pages (from-to)	101-128
Number of pages	27
Journal	Pharmacy
Volume	3
Issue number	3
DOIs	https://doi.org/10.3390/pharmacy3030101
Publication status	Published - 29 Jul 2015

Bibliographical note

© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).

Keywords

education
pharmacy
industry
Europe
biotechnology

Access to Document

10.3390/pharmacy3030101Licence: CC BY 3.0

Industrial pharmacy practice in biotechnology
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
Final published version, 4.61 MBLicence: CC BY 3.0

http://www.mdpi.com/2226-4787/3/3/101Licence: CC BY 3.0

Cite this

@article{c1ad5d53cf3d454da3b105cf35f8290f,

title = "A European competence framework for industrial pharmacy practice in biotechnology",

abstract = "Project Report: The PHAR-IN ({"}Competences for industrial pharmacy practice in biotechnology{"}) looked at whether there is a difference in how industrial employees and academics rank competences for practice in the biotechnological industry. A small expert panel consisting of the authors of this paper produced a biotechnology competence framework by drawing up an initial list of competences then ranking them in importance using a three-stage Delphi process. The framework was next evaluated and validated by a large expert panel of academics (n = 37) and industrial employees (n = 154). Results show that priorities for industrial employees and academics were similar. The competences for biotechnology practice that received the highest scores were mainly in: . {"}Research and Development{"}, . {"}Upstream{"} and {"}Downstream{"} Processing', {"} . {"}Product development and formulation{"}, {"} . {"}Aseptic processing{"}, .{"}Analytical methodology{"}, . {"}Product stability{"}, and . {"}Regulation{"}. The main area of disagreement was in the category {"}Ethics and drug safety{"} where academics ranked competences higher than did industrial employees.",

keywords = "education, pharmacy, industry, Europe, biotechnology",

author = "Jeffrey Atkinson and Pat Crowley and \{de Paepe\}, Kristien and Brian Gennery and Andries Koster and Luigi Martini and Vivien Moffat and Jane Nicholson and Gunther Pauwels and Giuseppe Ronsisvalle and Vitor Sousa and \{van Schravendijk\}, Chris and Keith Wilson",

note = "{\textcopyright} 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).",

year = "2015",

month = jul,

day = "29",

doi = "10.3390/pharmacy3030101",

language = "English",

volume = "3",

pages = "101--128",

journal = "Pharmacy",

issn = "2226-4787",

publisher = "MDPI AG",

number = "3",

}

TY - JOUR

T1 - A European competence framework for industrial pharmacy practice in biotechnology

AU - Atkinson, Jeffrey

AU - Crowley, Pat

AU - de Paepe, Kristien

AU - Gennery, Brian

AU - Koster, Andries

AU - Martini, Luigi

AU - Moffat, Vivien

AU - Nicholson, Jane

AU - Pauwels, Gunther

AU - Ronsisvalle, Giuseppe

AU - Sousa, Vitor

AU - van Schravendijk, Chris

AU - Wilson, Keith

N1 - © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).

PY - 2015/7/29

Y1 - 2015/7/29

N2 - Project Report: The PHAR-IN ("Competences for industrial pharmacy practice in biotechnology") looked at whether there is a difference in how industrial employees and academics rank competences for practice in the biotechnological industry. A small expert panel consisting of the authors of this paper produced a biotechnology competence framework by drawing up an initial list of competences then ranking them in importance using a three-stage Delphi process. The framework was next evaluated and validated by a large expert panel of academics (n = 37) and industrial employees (n = 154). Results show that priorities for industrial employees and academics were similar. The competences for biotechnology practice that received the highest scores were mainly in: . "Research and Development", . "Upstream" and "Downstream" Processing', " . "Product development and formulation", " . "Aseptic processing", ."Analytical methodology", . "Product stability", and . "Regulation". The main area of disagreement was in the category "Ethics and drug safety" where academics ranked competences higher than did industrial employees.

AB - Project Report: The PHAR-IN ("Competences for industrial pharmacy practice in biotechnology") looked at whether there is a difference in how industrial employees and academics rank competences for practice in the biotechnological industry. A small expert panel consisting of the authors of this paper produced a biotechnology competence framework by drawing up an initial list of competences then ranking them in importance using a three-stage Delphi process. The framework was next evaluated and validated by a large expert panel of academics (n = 37) and industrial employees (n = 154). Results show that priorities for industrial employees and academics were similar. The competences for biotechnology practice that received the highest scores were mainly in: . "Research and Development", . "Upstream" and "Downstream" Processing', " . "Product development and formulation", " . "Aseptic processing", ."Analytical methodology", . "Product stability", and . "Regulation". The main area of disagreement was in the category "Ethics and drug safety" where academics ranked competences higher than did industrial employees.

KW - education

KW - pharmacy

KW - industry

KW - Europe

KW - biotechnology

U2 - 10.3390/pharmacy3030101

DO - 10.3390/pharmacy3030101

M3 - Article

SN - 2226-4787

VL - 3

SP - 101

EP - 128

JO - Pharmacy

JF - Pharmacy

IS - 3

ER -

A European competence framework for industrial pharmacy practice in biotechnology

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this